A recombinant human soluble p55 tumor necrosis factor binding protein for the treatment of a number of disorders, including Crohn's disease, psoriasis and psoriatic arthritis; TNFbp (pharmacologic) is the dimeric polyethylene glycol linked form of the type I soluble receptor of tumor necrosis factor (TNF) that acts as a TNF inhibitor.
Substance
